Stock listing
Cboe Canada:MRVL Marvel Biosciences Corp Stock
Canadian listing (Cboe Canada) of Marvel Biosciences Corp · home listing TSXV:MRVL
Follow Marvel Biosciences Corp into a list and get an email when it puts out news.
Home listing price · TSXV:MRVL
$0.12 CAD 0.00 (0.0%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSXV:MRVL
- Day range
- $0.12 – $0.12 CADOct 30, 2026
- Volume
- 5,000 sharesOct 30, 2026
- Market cap
- $8.84M CADAt the close on Oct 30, 2026 · price × 73.68M shares outstanding
- 52-week range
- $0.095 – $0.25 CADLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $11,888 CADMedian day 34,511 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:MRVL · Home | $0.12 CAD | 0.00 (0.0%) | 5,000 | $0.12 | $0.12 | $0.12 | $0.12 | Close on Oct 30, 2026 |
| OTC:MBCOF | $0.08 USD | -0.005 (-5.3%) | 1,120 | $0.08 | $0.08 | $0.08 | $0.085 | Close on Oct 23, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · TSXV:MRVL · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.12 | 0.00 | 0.0% | $0.12 | $0.12 | $0.12 | 5,000 | |
| $0.12 | 0.00 | 0.0% | $0.125 | $0.125 | $0.12 | 5,569 | |
| $0.12 | 0.00 | 0.0% | $0.125 | $0.125 | $0.12 | 29,000 | |
| $0.12 | -0.005 | -4.0% | $0.12 | $0.12 | $0.12 | 85,605 | |
| $0.125 | +0.01 | +8.7% | $0.12 | $0.125 | $0.115 | 58,559 | |
| $0.115 | 0.00 | 0.0% | $0.12 | $0.12 | $0.115 | 30,833 | |
| $0.115 | -0.005 | -4.2% | $0.125 | $0.125 | $0.115 | 111,000 | |
| $0.12 | 0.00 | 0.0% | $0.12 | $0.12 | $0.12 | 2,109 | |
| $0.12 | +0.025 | +26.3% | $0.095 | $0.12 | $0.095 | 280,267 | |
| $0.095 | -0.005 | -5.0% | $0.10 | $0.10 | $0.095 | 27,525 | |
| $0.10 | 0.00 | 0.0% | $0.105 | $0.11 | $0.10 | 58,039 | |
| $0.10 | -0.01 | -9.1% | $0.105 | $0.105 | $0.10 | 118,800 | |
| $0.11 | 0.00 | 0.0% | $0.11 | $0.11 | $0.105 | 33,500 | |
| $0.11 | -0.005 | -4.3% | $0.11 | $0.11 | $0.11 | 53,258 | |
| $0.115 | 0.00 | 0.0% | $0.11 | $0.12 | $0.11 | 75,000 | |
| $0.115 | +0.01 | +9.5% | $0.105 | $0.115 | $0.105 | 148,996 | |
| $0.105 | -0.005 | -4.5% | $0.12 | $0.12 | $0.105 | 88,392 | |
| $0.11 | 0.00 | 0.0% | $0.11 | $0.12 | $0.11 | 177,779 | |
| $0.11 | -0.01 | -8.3% | $0.12 | $0.12 | $0.105 | 226,209 | |
| $0.12 | -0.03 | -20.0% | $0.15 | $0.15 | $0.12 | 474,666 | |
| $0.15 | -0.005 | -3.2% | $0.155 | $0.155 | $0.15 | 14,358 | |
| $0.155 | 0.00 | 0.0% | $0.155 | $0.16 | $0.155 | 27,118 | |
| $0.155 | +0.005 | +3.3% | $0.145 | $0.155 | $0.145 | 176,922 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.15 | $0.145 | 21,841 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.15 | $0.15 | 3,500 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.15 | $0.15 | 5,400 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.15 | $0.145 | 18,200 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.15 | $0.12 | 51,805 | |
| $0.15 | +0.005 | +3.4% | $0.145 | $0.15 | $0.145 | 6,515 | |
| $0.145 | 0.00 | 0.0% | $0.145 | $0.145 | $0.145 | 15,578 | |
| $0.145 | -0.005 | -3.3% | $0.145 | $0.15 | $0.145 | 18,001 | |
| $0.15 | 0.00 | 0.0% | $0.145 | $0.15 | $0.145 | 10,066 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.15 | $0.145 | 715,100 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.15 | $0.13 | 730,716 | |
| $0.15 | +0.01 | +7.1% | $0.15 | $0.15 | $0.125 | 57,296 | |
| $0.14 | 0.00 | 0.0% | $0.14 | $0.14 | $0.14 | 1,600 | |
| $0.14 | 0.00 | 0.0% | $0.145 | $0.145 | $0.14 | 17,900 | |
| $0.14 | -0.01 | -6.7% | $0.15 | $0.155 | $0.13 | 149,374 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.15 | $0.15 | 16,793 | |
| $0.15 | 0.00 | 0.0% | $0.15 | $0.155 | $0.14 | 43,596 | |
| $0.15 | -0.005 | -3.2% | $0.15 | $0.15 | $0.15 | 17,001 | |
| $0.155 | +0.005 | +3.3% | $0.15 | $0.155 | $0.145 | 36,014 | |
| $0.15 | -0.005 | -3.2% | $0.15 | $0.15 | $0.15 | 12,637 | |
| $0.155 | +0.005 | +3.3% | $0.15 | $0.155 | $0.145 | 82,926 | |
| $0.15 | 0.00 | 0.0% | $0.155 | $0.155 | $0.145 | 71,600 | |
| $0.15 | 0.00 | 0.0% | $0.145 | $0.155 | $0.145 | 70,333 | |
| $0.15 | -0.005 | -3.2% | $0.155 | $0.155 | $0.15 | 23,927 | |
| $0.155 | +0.005 | +3.3% | $0.16 | $0.16 | $0.155 | 19,610 | |
| $0.15 | -0.005 | -3.2% | $0.165 | $0.165 | $0.15 | 18,112 | |
| $0.155 | -0.01 | -6.1% | $0.155 | $0.165 | $0.155 | 44,356 | |
| $0.165 | +0.005 | +3.1% | $0.165 | $0.17 | $0.16 | 47,185 | |
| $0.16 | 0.00 | 0.0% | $0.165 | $0.165 | $0.16 | 12,111 | |
| $0.16 | -0.01 | -5.9% | $0.17 | $0.17 | $0.14 | 187,950 | |
| $0.17 | +0.01 | +6.3% | $0.165 | $0.17 | $0.165 | 62,500 | |
| $0.16 | 0.00 | 0.0% | $0.16 | $0.16 | $0.155 | 18,000 | |
| $0.16 | -0.005 | -3.0% | $0.17 | $0.17 | $0.16 | 8,500 | |
| $0.165 | 0.00 | 0.0% | $0.175 | $0.175 | $0.16 | 31,200 | |
| $0.165 | 0.00 | 0.0% | $0.17 | $0.17 | $0.155 | 31,608 | |
| $0.165 | +0.005 | +3.1% | $0.16 | $0.17 | $0.16 | 13,500 | |
| $0.16 | -0.005 | -3.0% | $0.18 | $0.18 | $0.15 | 35,521 | |
| $0.165 | -0.01 | -5.7% | $0.18 | $0.20 | $0.145 | 253,274 | |
| $0.175 | +0.025 | +16.7% | $0.17 | $0.19 | $0.155 | 121,975 | |
| $0.15 | -0.015 | -9.1% | $0.16 | $0.16 | $0.15 | 20,282 | |
| $0.165 | 0.00 | 0.0% | $0.165 | $0.165 | $0.16 | 48,887 |
- Ticker
- Cboe Canada:MRVL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Cboe Canada
- Currency
- CAD
What changed lately
Latest news release · Oct 21, 2026
CEO.CA's Inside the Boardroom: No Approved Drug Does What Marvel's Lead Candidate Can Do for Autism
Latest deck · February 2026
Investor Presentation (February 2026)
Investor deck · 15 slides
Latest news
CEO.CA's Inside the Boardroom: No Approved Drug Does What Marvel's Lead Candidate Can Do for Autism
Oct 21, 2026
Closed $0.12 (0.0%) on Oct 21, 2026
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
Oct 19, 2026
Closed $0.095 (-5.0%) on Oct 19, 2026
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
Oct 8, 2026
Closed $0.115 (+9.5%) on Oct 8, 2026
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
Oct 6, 2026
Closed $0.11 (0.0%) on Oct 6, 2026
Marvel Biosciences Announces Closing of Private Placement For Up To $3.0 Million
Sep 29, 2026
Closed $0.155 (0.0%) on Sep 30, 2026
Marvel Biosciences Provides Update on Private Placement for up to $3.0 Million
Sep 17, 2026
Closed $0.145 (0.0%) on Sep 18, 2026
Marvel Biosciences Announces Extension to Closing Date of Private Placement
Sep 9, 2026
Closed $0.14 (0.0%) on Sep 9, 2026
Marvel Biosciences Expands Private Placement to Quebec
Aug 19, 2026
Closed $0.165 (+3.1%) on Aug 19, 2026
Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X
Aug 5, 2026
Closed $0.165 (-5.7%) on Aug 5, 2026
Marvel Biosciences Announces Private Placement for up to $3.0 Million
Jul 16, 2026
Closed $0.15 (-6.3%) on Jul 17, 2026
Financings
Private placement of units
Sep 29, 2026 · US$1.13M
Closed: C$1.6M raised · C$0.15 a unit · 1 warrant at C$0.2 for 12 months · Raymond James Ltd. +5
Dealers: Raymond James Ltd. (finder), Canaccord Genuity Corp. (finder), Research Capital Corporation (finder), Acumen Capital Finance Partners Limited (finder), Hampton Securities (finder), Leede Financial Inc. (finder)
Use of proceeds: Deposit for phase 1 clinical trials of lead compound MB-204, general and administrative expenses and general working capital
Announced Jul 16, 2026 · Terms changed Aug 19, 2026 · Update Sep 9, 2026 · Update Sep 17, 2026 · Closed Sep 29, 2026
Decks
Investor Presentation (February 2026)
Investor deck · 15 slides · February 2026
Investor Presentation (December 2024)
Investor deck · 18 slides · December 2024
Investor Presentation (December 2024)
Investor deck · 19 slides · December 2024
Investor Presentation (May 2023)
Investor deck · 29 slides · May 2023
Marvel Biosciences Corp on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 100 in all · newest Oct 21, 2026 · oldest 2021
- Decks
- 5 decks · latest February 2026
Where Marvel Biosciences Corp is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:MRVL · Home listing | TSXV | Canada | CAD |
| Cboe Canada:MRVL · This page | Cboe Canada | Canada | CAD |
| OTC:MBCOF | OTC | United States | USD |
Log in to ask 6ix AI your own questions about Marvel Biosciences Corp.